SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is actively discussed following strategic shifts, including a new "Meta Compute" initiative focused on scaling AI infrastructure through significant nuclear energy partnerships, alongside reported workforce reductions in its Reality Labs division. The community is sharply divided, with some investors questioning the large capital expenditure and perceived lack of immediate returns, while others view these investments as essential for long-term growth and AI leadership.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is a top trending stock as investors analyze its J.P. Morgan Healthcare Conference presentation for critical updates on its oral VK2735 program and commercialization plans, reinforced by a recent Chief Commercial Officer hire and the completion of its obesity maintenance study enrollment. The community is sharply divided between bullish expectations for a significant partnership or buyout, driven by the drug's perceived 'best-in-class' potential, and concerns over stock price suppression and management's strategy within the highly competitive metabolic market.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is a focal point of market discussion following reports of new tariffs on countries trading with Iran and an investigation into Fed Chair Powell, prompting concerns over market stability and central bank independence. Despite this significant news, the community remains sharply divided, with many advocating to "buy the dip" and anticipating further rallies, while others warn of perceived manipulation and a potential sharp market reversal. This divergence in sentiment underscores the current uncertainty as the tech-heavy ETF shows resilience.

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.

Travere Therapeutics Inc

Travere Therapeutics is trending sharply lower following the FDA's request for additional clarification on the clinical benefit of FILSPARI for FSGS, a development that has caused significant market jitters ahead of its PDUFA decision. While many in the community are concerned this signals a potential Complete Response Letter, a notable counter-narrative suggests the sell-off is an overreaction, pointing to the company's strong commercial execution for FILSPARI in IgAN and solid financial standing as reasons to buy the dip.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is trending amid intense community debate, fueled by its ongoing underperformance and deep frustration with current management's ability to deliver sustained profitability. However, many investors remain bullish, highlighting the company's position as a global leader in virtual care and its potential to capture a significant share of the rapidly expanding AI healthcare market. Recent partnerships, such as with TytoCare for at-home diagnostics, and anticipation around the $50 billion Rural Health Transformation Program are seen as key catalysts, driving speculation of a significant long-term rebound for the stock.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

The SPDR Dow Jones Industrial Average ETF (DIA) is a central point of discussion as investors grapple with dramatic geopolitical events, including U.S. military actions in Venezuela, and the impact of domestic policy shifts like proposed interest rate caps and federal probes involving the Fed. While some traders highlight the Dow's surprising resilience and a rotation into "old economy" stocks amidst the turbulence, a strong contingent warns of extreme market overvaluation and the potential for a sharp correction due to escalating political and economic uncertainties. The community remains sharply divided on whether current gains represent genuine strength or a fragile "fake pump" driven by market manipulation.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo is trending amid a recent CFO transition and its reaffirmed commitment to prioritizing user growth and product innovation, despite strong preliminary Q4 metrics. The stock's significant decline has sparked a heated debate, with bulls viewing it as an oversold opportunity supported by strong fundamentals and AI integration, while bears argue the business model is vulnerable to free AI alternatives and cite ongoing chart weakness.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is a major talking point as the bank kicks off earnings season, with community discussions intensely focused on recent warnings about rising expenses and the potential impact of a proposed credit card interest rate cap. Investors are also digesting the bank's strategic move to take over the Apple Card program and its deeper foray into blockchain and tokenized funds, all while online chatter includes speculation regarding its market positions in commodities.

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.

Biodesix Inc

BDSX is trending due to strong preliminary Q4 and full-year 2025 results, which reported significant revenue growth and reaffirmed guidance for Adjusted EBITDA positivity. The community is actively discussing the stock's explosive volume and price action, with many speculating on continued momentum and a potential short squeeze. However, some investors express caution, pointing to the company's cash position and potential future dilution within the volatile biotech sector.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems is trending due to recent news of a partnership and a pre-production order for GPU-accelerated systems with a major U.S. defense contractor, alongside a strategic asset sale that strengthens its financial position to focus on core AI and edge computing. The community is buzzing with anticipation for a larger follow-on defense contract for 360-degree situational awareness in Army vehicles, with many seeing the company as a key player in the booming defense and AI infrastructure sectors despite its low market capitalization and float.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Valaris Limited (NYSE:VAL) Receives Consensus Recommendation of "Hold" from Analysts

Valaris Limited (NYSE:VAL - Get Free Report) has been given a consensus recommendation of "Hold" by the ten brokerages that are currently covering the firm, Marketbeat.com reports. Eight analysts...

Patterson-UTI (PTEN) Soars 6.4%: Is Further Upside Left in the Stock?

Patterson-UTI (PTEN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Valaris (NYSE:VAL) Upgraded by Zacks Research to "Strong-Buy" Rating

Zacks Research raised Valaris from a "hold" rating to a "strong-buy" rating in a research report on Tuesday...

Citigroup Lowers Valaris (NYSE:VAL) Price Target to $58.00

Citigroup dropped their price target on shares of Valaris from $62.00 to $58.00 and set a "neutral" rating for the company in a research report on Monday...

Shares of VAL Now Oversold

In trading on Wednesday, shares of Valaris Ltd (Symbol: VAL) entered into oversold territory, changing hands as low as $48.085 per share. We define oversold territory using the Relative Strength...

Valaris Limited (NYSE:VAL) Given Average Rating of "Hold" by Brokerages

Valaris Limited (NYSE:VAL - Get Free Report) has been assigned a consensus recommendation of "Hold" from the ten ratings firms that are currently covering the firm, Marketbeat Ratings reports. Nine...

Valaris (NYSE:VAL) Trading Down 6.3% - Here's What Happened

Valaris (NYSE:VAL) Trading Down 6.3% - What's Next...

Valaris Strengthens Contract Backlog With Multi-Year Drillship Award

VAL lands a $300 million, multi-year Shell contract for drillship DS-8 offshore Brazil, lifting its $2.5B backlog and strengthening cash flow visibility.

Valaris Limited $VAL Stock Holdings Lifted by Hara Capital LLC

Hara Capital LLC increased its position in Valaris Limited (NYSE:VAL - Free Report) by 29.1% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 173,382 shares of...

Marex Group plc Makes New $3.89 Million Investment in Valaris Limited $VAL

Marex Group plc acquired a new stake in shares of Valaris Limited (NYSE:VAL - Free Report) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor...

Valaris Ltd. engages in the provision of offshore contract drilling services to the international oil and gas industry. It operates through the following segments: Floaters, Jackups, ARO, and Other. The Floaters segment includes drillships and semisubmersible rigs. The Other segment is involved in management services on rigs owned by third-parties and the activities associated with arrangements with ARO under the bareboat charter arrangements. The company was founded in 1975 and is headquartered in Hamilton, Bermuda.

Valaris Ltd

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.46	--	--	N/A
Q3 '25	$1.02	$2.65	159.89%	BEAT
Q2 '25	$1.26	$1.61	27.90%	BEAT
Q1 '25	$1.23	-$0.53	-143.16%	MISSED
Q4 '24	$1.05	$1.88	79.41%	BEAT

VAL
Valaris Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest VAL News

VALValaris Ltd